Trials / Completed
CompletedNCT02849795
Evaluation of Adipokines and Fat Tissue in Psoriasis and Psoriatic Arthritis
Evaluation of Adipokines and Fat Tissue in Psoriasis and Psoriatic Arthritis and Assessment of Their Relations With the Risk of Cardiovascular Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 199 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Body composition analysis and especially body fat distribution in regions of interest (android and in particular intra-abdominal region) provides some information on the risk of cardiovascular disease. There is little data available on the body composition analysis in psoriasis and psoriatic arthritis (diseases with higher risk of cardiovascular disease), in particular data on fat distribution in regions of interest regarding the risk of cardiovascular disease. Adipokines, secreted by the adipose tissue, have pro or anti-inflammatory and metabolic properties that are interesting to explore in pathologies with a higher risk of cardiovascular disease like psoriasis or psoriatic arthritis. Adipokines have been investigated in psoriasis but fat tissue and in particular its distribution (android/visceral or intra-abdominal) has not been studied in parallel. Moreover, relation between adipokines and psoriasis area or severity has been studied but the relation between adipokines and cardiovascular risk factors has not yet been investigated. The aim of this study is to investigate relations between the body fat distribution, adipokines rates and the risk of cardiovascular disease of these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | bone densitometry | |
| OTHER | questionnaires | |
| OTHER | biological analyses |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2017-10-17
- Completion
- 2017-10-17
- First posted
- 2016-07-29
- Last updated
- 2018-02-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02849795. Inclusion in this directory is not an endorsement.